COMP <GO>
OHI vs BRK-B // FREE CASH FLOW YIELD
Omega Healthcare Investors Inc. (NYSE) VS. Berkshire Hathaway Inc. (NYSE) • 15-METRIC TALLY: OHI 6
— BRK-B 8
▲ FREE CASH FLOW YIELD LEADER: OHI
LAST: $46.98 (+0.30%) • MKT CAP: $14.19B
fcf-yield
5.81%
LAST: $542.49 (+0.10%) • MKT CAP: $1.16T
fcf-yield
2.09%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OHI VS. BRK-B)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | OHI | BRK-B | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 0.00% | 11.47% | -11.47 | BRK-B | /roic <GO> |
| EV/EBITDA & P/E Valuation | 95.0x | 9.7x | +85.32 | BRK-B | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 5.81% | 2.09% | +3.72 | OHI | /fcf-yield <GO> |
| Operating Margin | 0.10% | 27.80% | -27.70 | BRK-B | /operating-margins <GO> |
| Net Profit Margin | 0.10% | 22.30% | -22.20 | BRK-B | /net-margins <GO> |
| Revenue Growth (YoY) | 13.20% | 3.93% | +9.27 | OHI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 5.50% | 0.00% | +5.50 | OHI | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.89 | 2.85 | +0.04 | OHI | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 4/9 | +5.00 | OHI | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.20% | 3.55% | +3.65 | BRK-B | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.8 | 66.8 | -10.02 | BRK-B | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.08 | 0.61 | +0.47 | OHI | /macro-sensitivity <GO> |
| Forward P/E Multiple | 140.0x | 24.3x | +115.66 | BRK-B | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $14.19B | $1.16T | -$1.15T | BRK-B | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | OHI REV | BRK-B REV | OHI GROSS % | BRK-B GROSS % | OHI FCF | BRK-B FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.19B | $371.44B | 44.0% | — | $825.0M | $25.04B |
| FY 2024 | $1.05B | $371.43B | 44.0% | — | $702.1M | $11.62B |
| FY 2023 | $949.7M | $364.48B | 44.0% | — | $575.0M | $29.79B |
| FY 2022 | — | $302.02B | — | — | — | $21.89B |
| FY 2021 | — | $276.19B | — | — | — | $26.15B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OHI // BETA 1.08
BRK-B // BETA 0.61